We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Bruker (BRKR) Becomes Majority Investor in MIRO Analytical AG
Read MoreHide Full Article
Bruker Corporation (BRKR - Free Report) recently announced a majority investment in the Swiss start-up company, MIRO Analytical AG. The company serves atmospheric research and industrial customers, enabling fast, mobile, highest-precision air pollution and greenhouse gas (GHG) analysis to advance climate science, air pollution and industrial process monitoring.
The addition of MIRO will significantly bolster the gas-analysis spectroscopy portfolio of Bruker Optics Division, which is part of the Bruker Scientific Instruments (“BSI”) CALID segment. The financial details of the transaction were not disclosed.
About MIRO Analytical AG
Founded in 2018, the Zürich-based, young high-tech company, MIRO, is an innovative provider of fast, compact Quantum Cascade Laser-based multi-gas analyzers (MGA) for simultaneous, highest-precision monitoring of up to 10 trace gases. The company is anticipated to grow rapidly in the high-precision trace gas analysis market, which has a total addressable market of greater than $100 million annually.
Image Source: Zacks Investment Research
MIRO MGAs have applications in mobile monitoring of greenhouse gas and pollution sources to stationary air-quality monitoring. MIRO’s customers include leading climate scientists from research institutes, such as the German Space Agency, Research Center Jülich and French INRAE, with MGAs deployed in mobile labs in aircraft or vehicles, remote research stations and for laboratory experiments.
Significance of the News
MIRO’s products complement Bruker OMEGA and Matrix MG spectroscopic gas analyzers, with MIRO’s automated, compact, high-precision MGAs for real-time trace gas monitoring. Per Bruker’s representative, acquiring a majority stake in MIRO is an exciting step for its gas-analysis business, adding state-of-the-art QCL technology to the portfolio.
The strategic collaboration will advance climate research and environmental pollution analysis, as well as industrial trace-gas monitoring solutions, with fast, compact and highest-precision QCL MGAs.
Industry Prospects
Per a research report, the process spectroscopy market was valued at $18.86 billion in 2022 and is expected to witness a CAGR of 7% by 2030.
Strong Potential of CALID Group
Of late, Bruker’s CALID Group has been making decent progress, primarily because of the strong demand for differentiated instruments. The group is benefiting from sustained growth in the mass spectrometry business, including the FT-IR, Near IR and Raman molecular spectroscopy product lines.
Throughout the first half of 2023, Bruker’s timsTOF platform continued its adoption in 4D proteomics, epiproteomics and multiomics. Recently in June, the company announced transformative sensitivity on the 4D-Proteomics timsTOF platform with the launch of the new timsTOF Ultra. The mass spectrometer provides market-leading sensitivity and throughput with expanded peptide coverage and more accurate quantitation in unbiased 4D single-cell cell lines and tissue proteomics.
Bruker also announced a strategic partnership with Switzerland-based Biognosys AG earlier in January 2023. The collaboration is expected to create unique synergies between Biognosys’ versatile portfolio of proprietary proteomics services, software and kits and Bruker’s pioneering timsTOF platform.
Price Performance
In the past year, shares of the company have increased 8.8% against the industry’s decline of 8%.
Zacks Rank and Key Picks
Bruker Corporation currently carries a Zacks Rank #3 (Hold).
Haemonetics stock has risen 12.5% in the past year. Earnings estimates for Haemonetics have remained constant at $3.82 in 2023 and at $4.07 in 2024 in the past 30 days.
HAE’s earnings beat estimates in each of the trailing four quarters, delivering an average surprise of 19.39%. In the last reported quarter, it posted an earnings surprise of 38.16%.
Estimates for Quanterix’s 2023 loss per share have remained constant at 97 cents in the past 30 days. Shares of the company have surged 134.3% in the past year against the industry’s fall of 5.6%.
QTRX’s earnings beat estimates in each of the trailing four quarters, delivering an average surprise of 30.39%. In the last reported quarter, it posted an earnings surprise of 55.56%.
Estimates for Align Technology’s 2023 earnings have moved up from $8.77 to $8.78 per share in the past 30 days. Shares of the company have increased 31.2% in the past year compared with the industry’s rise of 16.7%.
ALGN’s earnings beat estimates in three of the trailing four quarters and missed in one. In the last reported quarter, it posted an earnings surprise of 9.90%.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Shutterstock
Bruker (BRKR) Becomes Majority Investor in MIRO Analytical AG
Bruker Corporation (BRKR - Free Report) recently announced a majority investment in the Swiss start-up company, MIRO Analytical AG. The company serves atmospheric research and industrial customers, enabling fast, mobile, highest-precision air pollution and greenhouse gas (GHG) analysis to advance climate science, air pollution and industrial process monitoring.
The addition of MIRO will significantly bolster the gas-analysis spectroscopy portfolio of Bruker Optics Division, which is part of the Bruker Scientific Instruments (“BSI”) CALID segment. The financial details of the transaction were not disclosed.
About MIRO Analytical AG
Founded in 2018, the Zürich-based, young high-tech company, MIRO, is an innovative provider of fast, compact Quantum Cascade Laser-based multi-gas analyzers (MGA) for simultaneous, highest-precision monitoring of up to 10 trace gases. The company is anticipated to grow rapidly in the high-precision trace gas analysis market, which has a total addressable market of greater than $100 million annually.
Image Source: Zacks Investment Research
MIRO MGAs have applications in mobile monitoring of greenhouse gas and pollution sources to stationary air-quality monitoring. MIRO’s customers include leading climate scientists from research institutes, such as the German Space Agency, Research Center Jülich and French INRAE, with MGAs deployed in mobile labs in aircraft or vehicles, remote research stations and for laboratory experiments.
Significance of the News
MIRO’s products complement Bruker OMEGA and Matrix MG spectroscopic gas analyzers, with MIRO’s automated, compact, high-precision MGAs for real-time trace gas monitoring. Per Bruker’s representative, acquiring a majority stake in MIRO is an exciting step for its gas-analysis business, adding state-of-the-art QCL technology to the portfolio.
The strategic collaboration will advance climate research and environmental pollution analysis, as well as industrial trace-gas monitoring solutions, with fast, compact and highest-precision QCL MGAs.
Industry Prospects
Per a research report, the process spectroscopy market was valued at $18.86 billion in 2022 and is expected to witness a CAGR of 7% by 2030.
Strong Potential of CALID Group
Of late, Bruker’s CALID Group has been making decent progress, primarily because of the strong demand for differentiated instruments. The group is benefiting from sustained growth in the mass spectrometry business, including the FT-IR, Near IR and Raman molecular spectroscopy product lines.
Throughout the first half of 2023, Bruker’s timsTOF platform continued its adoption in 4D proteomics, epiproteomics and multiomics. Recently in June, the company announced transformative sensitivity on the 4D-Proteomics timsTOF platform with the launch of the new timsTOF Ultra. The mass spectrometer provides market-leading sensitivity and throughput with expanded peptide coverage and more accurate quantitation in unbiased 4D single-cell cell lines and tissue proteomics.
Bruker also announced a strategic partnership with Switzerland-based Biognosys AG earlier in January 2023. The collaboration is expected to create unique synergies between Biognosys’ versatile portfolio of proprietary proteomics services, software and kits and Bruker’s pioneering timsTOF platform.
Price Performance
In the past year, shares of the company have increased 8.8% against the industry’s decline of 8%.
Zacks Rank and Key Picks
Bruker Corporation currently carries a Zacks Rank #3 (Hold).
Some better-ranked stocks in the broader medical space are Haemonetics (HAE - Free Report) , Quanterix (QTRX - Free Report) and Align Technology (ALGN - Free Report) , each carrying a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Haemonetics stock has risen 12.5% in the past year. Earnings estimates for Haemonetics have remained constant at $3.82 in 2023 and at $4.07 in 2024 in the past 30 days.
HAE’s earnings beat estimates in each of the trailing four quarters, delivering an average surprise of 19.39%. In the last reported quarter, it posted an earnings surprise of 38.16%.
Estimates for Quanterix’s 2023 loss per share have remained constant at 97 cents in the past 30 days. Shares of the company have surged 134.3% in the past year against the industry’s fall of 5.6%.
QTRX’s earnings beat estimates in each of the trailing four quarters, delivering an average surprise of 30.39%. In the last reported quarter, it posted an earnings surprise of 55.56%.
Estimates for Align Technology’s 2023 earnings have moved up from $8.77 to $8.78 per share in the past 30 days. Shares of the company have increased 31.2% in the past year compared with the industry’s rise of 16.7%.
ALGN’s earnings beat estimates in three of the trailing four quarters and missed in one. In the last reported quarter, it posted an earnings surprise of 9.90%.